FindTrial
Sign In

Syrup added as a flavoring in oral midazolam premedication improves tolerability in pediatric patients

Syrup added as a flavoring in oral midazolam premedication improves tolerability in pediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040229
Enrollment
Unknown
Registered
2020-11-25
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

syrup to cover biitter taste of midazolam

Interventions

Two groups:mixture of syrup with midazolam or without

Sponsors

The Eye & ENT Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: Peidatrics who undergo anterior ear fistula removal and eardrum catheterization.

Exclusion criteria

Exclusion criteria: Patients with a history of midazolam allergy, cognitive or motor developmentally delayed were the exclusion criteria. Children diagnosed with diabetes mellitus type I were also excluded.

Design outcomes

Primary

MeasureTime frame
tolerability of IV midazolam;—

Secondary

MeasureTime frame
levels of anxiety;—

Countries

China

Contacts

Public ContactShen Xia

Shanghai Eye &ENT Hospital

zlsx@yahoo.com+86 021-64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026